{
  "DOI": "10.1007/s12687-021-00559-8",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-021-00559-8",
  "alternative-id": [
    "559"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "23 August 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "18 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "2 November 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study was approved by the Peter MacCallum Cancer Centre and King Edward Memorial Hospital Human Research Ethics Committees."
    },
    {
      "group": {
        "label": "Consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All interviewees gave their consent to participate in interviews."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 5,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-5086-0784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Meiser",
      "given": "Bettina",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Monnik",
      "given": "Melissa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Austin",
      "given": "Rachel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nichols",
      "given": "Cassandra",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cops",
      "given": "Elisa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Salmon",
      "given": "Lucinda",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Spurdle",
      "given": "Amanda B.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Macrae",
      "given": "Finlay",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Taylor",
      "given": "Natalie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pachter",
      "given": "Nicholas",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "James",
      "given": "Paul",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kaur",
      "given": "Rajneesh",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        11,
        2
      ]
    ],
    "date-time": "2021-11-02T05:02:30Z",
    "timestamp": 1635829350000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        1,
        28
      ]
    ],
    "date-time": "2022-01-28T07:17:46Z",
    "timestamp": 1643354266000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001102",
      "award": [
        "CSR 18-01"
      ],
      "doi-asserted-by": "publisher",
      "name": "cancer council nsw"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        4
      ]
    ],
    "date-time": "2024-04-04T08:25:41Z",
    "timestamp": 1712219141923
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        11,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2022,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            11,
            2
          ]
        ],
        "date-time": "2021-11-02T00:00:00Z",
        "timestamp": 1635811200000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            11,
            2
          ]
        ],
        "date-time": "2021-11-02T00:00:00Z",
        "timestamp": 1635811200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-021-00559-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-021-00559-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-021-00559-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "59-73",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        11,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        11,
        2
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1111/nyas.12614",
      "author": "N Aronson",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "issue": "1",
      "journal-title": "Ann N Y Acad Sci",
      "key": "559_CR1",
      "unstructured": "Aronson N (2015) Making personalized medicine more affordable. Ann N Y Acad Sci 1346(1):81–89. https://doi.org/10.1111/nyas.12614",
      "volume": "1346",
      "year": "2015"
    },
    {
      "key": "559_CR2",
      "unstructured": "Australian Institute of Health and Welfare (2016) Australia’s health 2016 series No 15. Cat. no. AUS 199. AIHW, Canberra"
    },
    {
      "DOI": "10.1038/ajg.2010.120",
      "author": "P Barrow",
      "doi-asserted-by": "publisher",
      "first-page": "1719",
      "issue": "13",
      "journal-title": "Br J Surg",
      "key": "559_CR3",
      "unstructured": "Barrow P, Khan M, Lalloo F, Evans D, Hill J (2013a) Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Br J Surg 100(13):1719–1731. https://doi.org/10.1038/ajg.2010.120",
      "volume": "100",
      "year": "2013"
    },
    {
      "DOI": "10.1002/bjs.9316",
      "author": "P Barrow",
      "doi-asserted-by": "publisher",
      "first-page": "1719",
      "issue": "13",
      "journal-title": "Br J Surg",
      "key": "559_CR4",
      "unstructured": "Barrow P, Khan M, Lalloo F, Evans D, Hill J (2013b) Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg 100(13):1719–1731. https://doi.org/10.1002/bjs.9316",
      "volume": "100",
      "year": "2013"
    },
    {
      "DOI": "10.1191/1478088706qp063oa",
      "author": "V Braun",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "2",
      "journal-title": "Qual Res Psychol",
      "key": "559_CR5",
      "unstructured": "Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101. https://doi.org/10.1191/1478088706qp063oa",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0140-6736(20)30366-4",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "1855",
      "journal-title": "Lancet",
      "key": "559_CR6",
      "unstructured": "Burn J, Sheth H, Elliott E, Reed L, Macrae F, Mecklin J et al (2020) Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet 395:1855–1863. https://doi.org/10.1016/S0140-6736(20)30366-4",
      "volume": "395",
      "year": "2020"
    },
    {
      "key": "559_CR7",
      "unstructured": "Cancer Institute NSW (2018) Mismatch repair (MMR) genetic testing. https://www.eviq.org.au/. Accessed 1 August 2021"
    },
    {
      "key": "559_CR8",
      "unstructured": "Clinical Oncological Society of Australasia \u0026 Human Genetics Society of Australasia (2018) Universal tumour screening for evidence of mismatch repair deficiency: a national strategy to identify people with Lynch Syndrome. https://www.hgsa.org.au/documents/item/9171. Accessed 1 August 2021"
    },
    {
      "DOI": "10.1177/1049732305284002",
      "author": "L d'Agincourt-Canning",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "issue": "1",
      "journal-title": "Qual Health Res",
      "key": "559_CR9",
      "unstructured": "d’Agincourt-Canning L (2006) Genetic testing for hereditary breast and ovarian cancer: responsibility and choice. Qual Health Res 16(1):97–118. https://doi.org/10.1177/1049732305284002",
      "volume": "16",
      "year": "2006"
    },
    {
      "author": "E D'Andrea",
      "first-page": "45",
      "issue": "4 Suppl 1",
      "journal-title": "Epidemiol Prev",
      "key": "559_CR10",
      "unstructured": "D’Andrea E, Marzuillo C, Pelone F, Vito D, Villari P (2015) Genetic testing and economic evaluations: a systematic review of the literature. Epidemiol Prev 39(4 Suppl 1):45–50 https://pubmed.ncbi.nlm.nih.gov/26499415/",
      "volume": "39",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S0140-6736(04)17034-7",
      "author": "C De Angelis",
      "doi-asserted-by": "publisher",
      "first-page": "873",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "559_CR11",
      "unstructured": "De Angelis C, Drazen J, Frizelle F, Haug C, Hoey J, Horton R et al (2005) Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Arterioscler Thromb Vasc Biol 25:873–874. https://doi.org/10.1016/S0140-6736(04)17034-7",
      "volume": "25",
      "year": "2005"
    },
    {
      "key": "559_CR12",
      "unstructured": "Department of Health AG (2021a) Medicare Benefits Schedule. http://www9.health.gov.au/mbs/fullDisplay.cfm?type=item\u0026q=73295\u0026qt=item. Accessed on 3 February 2021"
    },
    {
      "key": "559_CR13",
      "unstructured": "Department of Health AG (2021b) Medicare Benefits Schedule. http://www9.health.gov.au/mbs/fullDisplay.cfm?type=item\u0026q=73296\u0026qt=ItemID. Accessed on 3 February 2021"
    },
    {
      "DOI": "10.1002/ajmg.1493",
      "author": "M Esplen",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Am J Med Genet",
      "key": "559_CR14",
      "unstructured": "Esplen M, Madlensky L, Butler K, McKinnon W, Bapat B, Wong J, Aronson M, Gallinger S (2001) Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 103:9–15. https://doi.org/10.1002/ajmg.1493",
      "volume": "103",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ejhg.2013.64",
      "author": "H Etchegary",
      "doi-asserted-by": "publisher",
      "first-page": "1338",
      "journal-title": "Eur J Hum Genet",
      "key": "559_CR15",
      "unstructured": "Etchegary H, Green J, Dicks E, Pullman D, Street C, Parfrey P (2013) Consulting the community: public expectations and attitudes about genetics research. Eur J Hum Genet 21:1338–1343. https://doi.org/10.1038/ejhg.2013.64",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1111/hex.12122",
      "author": "H Etchegary",
      "doi-asserted-by": "publisher",
      "first-page": "1413",
      "journal-title": "Health Expect",
      "key": "559_CR16",
      "unstructured": "Etchegary H, Green J, Parfrey P, Street C, Pullman D (2015) Community engagement with genetics: public perceptions and expectations about genetics research. Health Expect 18:1413–1425. https://doi.org/10.1111/hex.12122",
      "volume": "18",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10549-013-2583-1",
      "author": "D Evans",
      "doi-asserted-by": "publisher",
      "first-page": "135",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "559_CR17",
      "unstructured": "Evans D, Ingham S, Baildam A, Ross G, Lalloo F, Buchan I, Howell A (2013) Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat 140(1):135–142. https://doi.org/10.1007/s10549-013-2583-1",
      "volume": "140",
      "year": "2013"
    },
    {
      "DOI": "10.1089/bio.2014.0032",
      "author": "A Ewing",
      "doi-asserted-by": "publisher",
      "first-page": "98",
      "journal-title": "Biopreserv Biobank",
      "key": "559_CR18",
      "unstructured": "Ewing A, Erby L, Bollinger J, Tetteyfio E, Ricks-Santi L, Kaufman D (2015) Demographic differences in willingness to provide broad and narrow consent for biobank research. Biopreserv Biobank 13:98–106. https://doi.org/10.1089/bio.2014.0032",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s12687-017-0323-7",
      "author": "L Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "J Community Genet",
      "key": "559_CR19",
      "unstructured": "Forrest L, Mitchell G, Thrupp L, Petelin L, Richardson K, Mascarenhas L, Young M (2018) Consumer attitudes towards the establishment of a national Australian familial cancer research database by the Inherited Cancer Connect (ICCon) Partnership. J Community Genet 9:57–64. https://doi.org/10.1007/s12687-017-0323-7",
      "volume": "9",
      "year": "2018"
    },
    {
      "author": "G Geller",
      "first-page": "377",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "559_CR20",
      "unstructured": "Geller G, Doksum T, Bernhardt BA, Metz SA (1999) Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women’s decisions. Cancer Epidemiol Biomark Prev 8:377–383 https://pubmed.ncbi.nlm.nih.gov/10207643/",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1038/s41431-020-00782-w",
      "author": "M Haas",
      "doi-asserted-by": "publisher",
      "first-page": "687",
      "journal-title": "Eur J Hum Genet",
      "key": "559_CR21",
      "unstructured": "Haas M, Teare H, Prictor M, Ceregra G, Vidgen M, Bunker D et al (2021) ‘CTRL’: an online, Dynamic Consent and participant engagement platform working towards solving the complexities of consent in genomic research. Eur J Hum Genet 29:687–698. https://doi.org/10.1038/s41431-020-00782-w",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1136/jme.2009.029264",
      "author": "N Hallowell",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "issue": "1",
      "journal-title": "J Med Ethic",
      "key": "559_CR22",
      "unstructured": "Hallowell N, Cooke S, Crawford G, Lucassen A, Parker M, Snowdon C (2010) An investigation of patients’ motivations for their participation in genetics-related research. J Med Ethic 36(1):37–45. https://doi.org/10.1136/jme.2009.029264",
      "volume": "36",
      "year": "2010"
    },
    {
      "DOI": "10.1016/s0016-5085(00)70168-5",
      "author": "H Jarvinen",
      "doi-asserted-by": "publisher",
      "first-page": "829",
      "journal-title": "Gastroenterology",
      "key": "559_CR23",
      "unstructured": "Jarvinen H, Aarnio M, Mustonen H (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834. https://doi.org/10.1016/s0016-5085(00)70168-5",
      "volume": "118",
      "year": "2000"
    },
    {
      "DOI": "10.1038/gim.2012.45",
      "author": "D Kaufman",
      "doi-asserted-by": "publisher",
      "first-page": "787",
      "issue": "9",
      "journal-title": "Genet Med",
      "key": "559_CR24",
      "unstructured": "Kaufman D, Bollinger J, Dvoskin R, Scott J (2012) Preferences for opt-in and opt-out enrollment and consent models in biobank research: a national survey of Veterans Administration patients. Genet Med 14(9):787–794. https://doi.org/10.1038/gim.2012.45",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2458-13-114",
      "doi-asserted-by": "publisher",
      "key": "559_CR25",
      "unstructured": "Kerath S, Klein G, Kern M, Shapira J, Witthuhn J, Norohna N et al (2013) Beliefs and attitudes towards participating in genetic research—a population based cross-sectional study. BMC Public Health 13(114). https://doi.org/10.1186/1471-2458-13-114"
    },
    {
      "DOI": "10.1001/jama.2017.7112",
      "author": "K Kuchenbaecker",
      "doi-asserted-by": "publisher",
      "first-page": "2402",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "559_CR26",
      "unstructured": "Kuchenbaecker K, Hopper J, Barnes D et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416. https://doi.org/10.1001/jama.2017.7112",
      "volume": "317",
      "year": "2017"
    },
    {
      "DOI": "10.1186/bcr2194",
      "author": "B Meiser",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "journal-title": "Breast Cancer Res",
      "key": "559_CR27",
      "unstructured": "Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C, Mitchell G (2008) Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 10:216. https://doi.org/10.1186/bcr2194",
      "volume": "10",
      "year": "2008"
    },
    {
      "author": "MB Miles",
      "edition": "3rd",
      "key": "559_CR28",
      "unstructured": "Miles MB, Huberman AM, Saldana J (2014) Qualitative data analysis: a methods sourcebook, 3rd edn. Sage, London",
      "volume-title": "Qualitative data analysis: a methods sourcebook",
      "year": "2014"
    },
    {
      "DOI": "10.1056/NEJMoa1611310",
      "author": "M Mirza",
      "doi-asserted-by": "publisher",
      "first-page": "2154",
      "journal-title": "N Engl J Med",
      "key": "559_CR29",
      "unstructured": "Mirza M, Monk B, Herrstedt J, Oza A, Mahner S, Redondo A et al (2016) Niraparib Maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med 375:2154–2164. https://doi.org/10.1056/NEJMoa1611310",
      "volume": "375",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMoa1810858",
      "author": "K Moore",
      "doi-asserted-by": "publisher",
      "first-page": "2495",
      "journal-title": "N Engl J Med",
      "key": "559_CR30",
      "unstructured": "Moore K, Colombo N, Scambia G, Kim B, Oaknin A, Friedlander M et al (2018) Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med 379:2495–2505. https://doi.org/10.1056/NEJMoa1810858",
      "volume": "379",
      "year": "2018"
    },
    {
      "DOI": "10.1034/j.1399-0004.2000.570508.x",
      "author": "KA Phillips",
      "doi-asserted-by": "publisher",
      "first-page": "376",
      "journal-title": "Clin Genet",
      "key": "559_CR31",
      "unstructured": "Phillips KA, Warner E, Meschino WE, Hunter J, Abdolell M, Glendon G, Andrulis I, Goodwin PJ (2000) Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet 57:376–383. https://doi.org/10.1034/j.1399-0004.2000.570508.x",
      "volume": "57",
      "year": "2000"
    },
    {
      "DOI": "10.1038/gim.2013.59",
      "author": "J Platt",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Genet Med",
      "key": "559_CR32",
      "unstructured": "Platt J, Bollinger J, Dvoskin R, Kardia S, Kaufman D (2014) Public preferences regarding informed consent models for participation in population-based genomic research. Genet Med 16:11–18. https://doi.org/10.1038/gim.2013.59",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1470-2045(17)30469-2",
      "author": "E Puiade-Lauraine",
      "doi-asserted-by": "publisher",
      "first-page": "1274",
      "issue": "9",
      "journal-title": "Lancet",
      "key": "559_CR33",
      "unstructured": "Puiade-Lauraine E, Ledermann J, Selle F, Gebski V, Penson R, Oza A et al (2017) Olaparib tablets as maintenance therapy in patients with platinum- sensitive, relapsed ovarian cancer and A BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet 8(9):1274–1284. https://doi.org/10.1016/S1470-2045(17)30469-2",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s11019-013-9480-6",
      "author": "G Quinn",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "journal-title": "Med Health Care Philos",
      "key": "559_CR34",
      "unstructured": "Quinn G, Murphy D, Pratt C, Muñoz-Antonia T, Guerra L, Schabath M, Leon M, Haura E (2013) Altruism in terminal cancer patients and rapid tissue donation program: does the theory apply. Med Health Care Philos 16:857–864. https://doi.org/10.1007/s11019-013-9480-6",
      "volume": "16",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "559_CR35",
      "unstructured": "Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van ’t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL, Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van ‘t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. [see comment]. J Clin Oncol 22(6):1055–1062. https://doi.org/10.1200/JCO.2004.04.188",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "T Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "J Natl Cancer Inst",
      "key": "559_CR36",
      "unstructured": "Rebbeck T, Kauff N, Domchek S (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87. https://doi.org/10.1093/jnci/djn442",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1002/humu.21628",
      "author": "A Spurdle",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "559_CR37",
      "unstructured": "Spurdle A, Healey S, Devereau A, Hogervorst F, Monteiro A, Nathanson K et al (2012) ENIGMA - Evidence-based Network for the Interpretation of Germline Mutant Alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat 33(1):2–7. https://doi.org/10.1002/humu.21628",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrclinonc.2010.175",
      "author": "A Trainer",
      "doi-asserted-by": "publisher",
      "first-page": "708",
      "journal-title": "Nat Rev Clinic Oncol",
      "key": "559_CR38",
      "unstructured": "Trainer A, Lewis C, Tucker K, Meiser B, Friedlander M, Ward R (2010) Treatment-focused genetic assessment in breast cancer - the evolving role of the familial cancer services. Nat Rev Clinic Oncol 7:708–717. https://doi.org/10.1038/nrclinonc.2010.175",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMoa2105215",
      "doi-asserted-by": "publisher",
      "key": "559_CR39",
      "unstructured": "Tutt A, Garber J, Kaufman B, Viale G, Fu D, Fumagalli D (2021) Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med 384(25):2394–2405. https://doi.org/10.1056/NEJMoa2105215"
    },
    {
      "DOI": "10.1007/s10689-016-9897-1",
      "author": "H Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "429",
      "journal-title": "Fam Cancer",
      "key": "559_CR40",
      "unstructured": "Vasen H, Velthuizen M, Kleibeuker J, Menko F, Nagengast F, Cats A et al (2016) Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry. Fam Cancer 15:429–435. https://doi.org/10.1007/s10689-016-9897-1",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10689-018-0110-6",
      "author": "JR Vos",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "559_CR41",
      "unstructured": "Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N (2019) Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes. Fam Cancer 18(2):281–284. https://doi.org/10.1007/s10689-018-0110-6",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1136/bmj.332.7540.544",
      "author": "D Wendler",
      "doi-asserted-by": "publisher",
      "first-page": "544",
      "journal-title": "BMJ",
      "key": "559_CR42",
      "unstructured": "Wendler D (2006) One-time general consent for research on biological samples. BMJ 332:544–547. https://doi.org/10.1136/bmj.332.7540.544",
      "volume": "332",
      "year": "2006"
    }
  ],
  "reference-count": 42,
  "references-count": 42,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-021-00559-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}